| Period Ending | Mar 30, 2012 | Mar 30, 2011 |
|---|
|
Total Revenue
|
-
|
-
| | Cost of Revenue |
-
|
-
| | |
Gross Profit
|
-
|
-
| |
|
Operating Expenses |
|
Research Development | 1,041 | 2,971 |
|
Selling General and Administrative | 5,064 | 6,225 |
|
Non Recurring |
-
|
-
|
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | | |
Operating Income or Loss
|
(6,105)
|
(9,196)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 139 | 143 |
|
Earnings Before Interest And Taxes | (5,966) | (9,053) |
|
Interest Expense |
-
|
-
|
|
Income Before Tax | (5,966) | (9,053) |
|
Income Tax Expense |
-
|
-
|
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | (5,966) | (9,053) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | | |
Net Income
|
(5,966)
|
(9,053)
| | Preferred Stock And Other Adjustments |
-
|
-
| | |
Net Income Applicable To Common Shares
|
(5,966)
|
(9,053)
|
|
0.91%